373 related articles for article (PubMed ID: 18949510)
21. Review: treatment of gastroesophageal reflux disease in the elderly.
Poh CH; Navarro-Rodriguez T; Fass R
Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
[TBL] [Abstract][Full Text] [Related]
22. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
[TBL] [Abstract][Full Text] [Related]
23. Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease.
Gold BD; Pilmer B; Kierkuś J; Hunt B; Perez MC; Gremse D
Dig Dis Sci; 2017 Nov; 62(11):3059-3068. PubMed ID: 28916953
[TBL] [Abstract][Full Text] [Related]
24. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?
McColl E; Junghard O; Wiklund I; Revicki DA
Am J Gastroenterol; 2005 Jan; 100(1):11-8. PubMed ID: 15654774
[TBL] [Abstract][Full Text] [Related]
25. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
[TBL] [Abstract][Full Text] [Related]
26. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
27. [Heartburn: in short-term treatment you have the choice!].
Camain JY; Wiesel PH; Peytremann-Bridevaux I
Praxis (Bern 1994); 2012 Feb; 101(5):331-2. PubMed ID: 22377981
[No Abstract] [Full Text] [Related]
28. Characteristics of gastroesophageal reflux in adults with cystic fibrosis.
Sabati AA; Kempainen RR; Milla CE; Ireland M; Schwarzenberg SJ; Dunitz JM; Khan KM
J Cyst Fibros; 2010 Sep; 9(5):365-70. PubMed ID: 20674518
[TBL] [Abstract][Full Text] [Related]
29. The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.
Jha LK; Maradey-Romero C; Gadam R; Hershcovici T; Fass OZ; Quan SF; Guillen J; Fass R
Neurogastroenterol Motil; 2015 Feb; 27(2):237-45. PubMed ID: 25484104
[TBL] [Abstract][Full Text] [Related]
30. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of gastroesophageal reflux in a Tunisian primary care population determined by patient interview.
Ben Chaabane N; El Jeridi N; Ben Salem K; Hellara O; Loghmari H; Melki W; Bdioui F; Safer L; Soltani M; Saffar H
Dis Esophagus; 2012 Jan; 25(1):4-9. PubMed ID: 21595777
[TBL] [Abstract][Full Text] [Related]
32. Treatment of intermittent reflux symptoms: one size does not fit all.
DeVault KR
J Clin Gastroenterol; 2007 Jul; 41(6):546-7. PubMed ID: 17577109
[No Abstract] [Full Text] [Related]
33. Prevalence of gastroesophageal reflux disease in Moscow.
Bor S; Lazebnik LB; Kitapcioglu G; Manannikof I; Vasiliev Y
Dis Esophagus; 2016; 29(2):159-65. PubMed ID: 25604401
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.
Manabe N; Haruma K; Ito M; Takahashi N; Takasugi H; Wada Y; Nakata H; Katoh T; Miyamoto M; Tanaka S
Dis Esophagus; 2012 Jul; 25(5):373-80. PubMed ID: 22050449
[TBL] [Abstract][Full Text] [Related]
35. [Gastroesophageal reflux in the French general population: national survey of 8000 adults].
Bretagne JF; Richard-Molard B; Honnorat C; Caekaert A; Barthélemy P
Presse Med; 2006 Jan; 35(1 Pt 1):23-31. PubMed ID: 16462660
[TBL] [Abstract][Full Text] [Related]
36. Marked increase in proton pump inhibitors use in Australia.
Hollingworth S; Duncan EL; Martin JH
Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646
[TBL] [Abstract][Full Text] [Related]
37. Endoluminal gastroplication for the treatment of gastroesophageal reflux disease: a 2-year prospective pilot study from Taiwan.
Liao CC; Lee CL; Lin BR; Bai CH; Hsieh YH; Wu CH; Gostout CJ
J Gastroenterol Hepatol; 2008 Mar; 23(3):398-405. PubMed ID: 18318824
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.
Lee YJ; Redd M; Bayman L; Frederickson N; Valestin J; Schey R
Dis Esophagus; 2015 Jan; 28(1):19-24. PubMed ID: 24382218
[TBL] [Abstract][Full Text] [Related]
39. Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.
Jones R; Horbach S; Sander P; Rydén-Bergsten T
Pharmacoeconomics; 2003; 21(15):1091-102. PubMed ID: 14596628
[TBL] [Abstract][Full Text] [Related]
40. Role of the primary care provider in the diagnosis and management of heartburn.
Kushner PR
Curr Med Res Opin; 2010 Apr; 26(4):759-65. PubMed ID: 20095795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
